Skip to main content
. 2006 Aug 14;12(30):4794–4806. doi: 10.3748/wjg.v12.i30.4794

Table 7.

Drugs for the treatment of CD

Drug Infliximab
Dosage 5 mg/kg per infusion; usually started at wk 0, 2, and 6 and then repeated every 8 wk if necessary
Indications Chronically active disease, steroid-refractory and steroid-dependency, maintenance, fistulae
Important side effects Nausea, headache, abdominal pain, infections, sepsis; infusions reactions (early or delayed), reactivation of tuberculosis
Monitoring Vital signs around infusion
Pregnancy Unknown
Comments Exclude tuberculosis before infusions, consider concommittant use of imunosuppressants (azathioprine) to reduce antibody formation